Unknown

Dataset Information

Photodynamic therapy of melanoma by blue-light photoactivation of flavin mononucleotide.


ABSTRACT: Melanoma is one of the most aggressive and lethal form of cancer. Photodynamic therapy (PDT) is a clinically approved technique for cancer treatment, including non-melanoma skin cancer. However, the most of conventional photosensitizers are of low efficacy against melanoma due to the possible dark toxicity at high drug concentrations, melanin pigmentation, and induction of anti-oxidant defense mechanisms. In the current research we propose non-toxic flavin mononucleotide (FMN), which is a water-soluble form of riboflavin (vitamin B2) as a promising agent for photodynamic therapy of melanoma. We demonstrated selective accumulation of FMN in melanoma cells in vivo and in vitro in comparison with keratinocytes and fibroblasts. Blue light irradiation with dose 5 J/cm2 of melanoma ce

SUBMITTER: Akasov RA 

PROVIDER: S-EPMC6609768 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature